TargetMol

Cyclopentolate Hydrochloride

Product Code:
 
TAR-T8383
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8383-10mg10mg£96.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8383-1mL1 mL * 10 mM (in DMSO)£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8383-25mg25mg£124.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8383-50mg50mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8383-100mg100mg£210.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Cyclopentolate Hydrochloride is a muscarinic acetylcholine receptors antagonist with Kis of 1.62, 27.5, and 2.63 nM for M1, M2, and M3 receptors, respectively.
CAS:
5870-29-1
Formula:
C17H26ClNO3
Molecular Weight:
327.85
Pathway:
Neuroscience
Purity:
0.9828
SMILES:
Cl.CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1
Target:
AChR

References

Ishikawa H , Desantis L , Patil P N . Selectivity of Muscarinic Agonists Including (?)-Aceclidine and Antimuscarinics on the Human Intraocular Muscles[J]. Journal of Ocular Pharmacology & Therapeutics, 1998, 14(4):363-373. Akemi Wakayama.et al.Incidence of Side Effects of Topical Atropine Sulfate and Cyclopentolate Hydrochloride for Cycloplegia in Japanese Children: A Multicenter Study.Multicenter Study Jpn J Ophthalmol. 2018 Sep;62(5):531-536.